StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$44.84−1.52 (-3.28%)

Close on Nov 17, 2026Market cap $3.20BP/E –Yield –

Pulse Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Pulse Biosciences's profit margin for the twelve months ending Jun 30, 2026 was -6755.8%. For fiscal 2025 it was -20794.6%, against -8357.9% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-20794.6%−12436.7
FY2022Dec 31, 2022-8357.9%−3868.4
FY2021Dec 31, 2021-4489.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-5681.3%−399.8
Q1 FY2026Mar 31, 2026-4633.7%−743.4
Q4 FY2025Dec 31, 2025-6603.4%−4776.9
Q3 FY2025Sep 30, 2025-22540.7%−20052.5
Q2 FY2022Jun 30, 2022-5281.5%–
Q1 FY2022Mar 31, 2022-3890.3%–
Q4 FY2021Dec 31, 2021-1826.5%–
Q3 FY2021Sep 30, 2021-2488.2%–

More Pulse Biosciences figures

See a number that looks wrong?